US Patent Issued to NEW YORK MEDICAL COLLEGE on Feb. 17 for "Intranasal neuropeptides for use in stress-related impairments" (New York Inventor)

ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,551,533, issued on Feb. 17, was assigned to NEW YORK MEDICAL COLLEGE (Valhalla, N.Y.).

"Intranasal neuropeptides for use in stress-related impairments" was invented by Esther L. Sabban (Bronx, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Intranasal neuropeptide Y (NPY) analogs having D-amino acids, such as [D26-His]-NPY are provided for early intervention to prevent or to treat, to reverse, or reduce symptoms of stress-related impairments such as PTSD, depression, substance abuse, and/or memory deficits following exposure to traumatic or surgical stress."

The patent was filed on March 18, 2020, under Application No. 17/440,445.

*For further inf...